LA MARCA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.718
AS - Asia 13.192
EU - Europa 10.135
SA - Sud America 2.073
AF - Africa 313
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 19
Totale 55.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.221
SG - Singapore 4.325
GB - Regno Unito 2.784
CN - Cina 2.780
IT - Italia 2.006
HK - Hong Kong 1.947
BR - Brasile 1.603
VN - Vietnam 1.518
SE - Svezia 1.121
DE - Germania 876
FI - Finlandia 790
BD - Bangladesh 654
UA - Ucraina 593
RU - Federazione Russa 510
TR - Turchia 424
FR - Francia 400
IN - India 285
CA - Canada 256
KR - Corea 253
BG - Bulgaria 243
AR - Argentina 175
NL - Olanda 171
ID - Indonesia 170
MX - Messico 135
JP - Giappone 134
ES - Italia 113
IQ - Iraq 111
ZA - Sudafrica 87
EC - Ecuador 69
PK - Pakistan 69
RO - Romania 64
AU - Australia 62
PL - Polonia 61
AE - Emirati Arabi Uniti 59
PH - Filippine 59
CO - Colombia 57
IR - Iran 52
IE - Irlanda 48
MY - Malesia 48
CL - Cile 47
VE - Venezuela 46
UZ - Uzbekistan 45
DZ - Algeria 42
MA - Marocco 42
BE - Belgio 37
LT - Lituania 37
CH - Svizzera 36
DK - Danimarca 35
CZ - Repubblica Ceca 33
AT - Austria 32
KE - Kenya 32
EG - Egitto 30
PY - Paraguay 29
TW - Taiwan 29
TH - Thailandia 26
SA - Arabia Saudita 25
JO - Giordania 24
NP - Nepal 24
AL - Albania 20
TN - Tunisia 20
JM - Giamaica 19
CR - Costa Rica 17
DO - Repubblica Dominicana 17
NZ - Nuova Zelanda 17
PE - Perù 17
AZ - Azerbaigian 16
BO - Bolivia 16
KZ - Kazakistan 16
HR - Croazia 15
IL - Israele 15
NG - Nigeria 15
NO - Norvegia 14
LV - Lettonia 12
MD - Moldavia 12
PS - Palestinian Territory 12
HN - Honduras 11
PT - Portogallo 11
GR - Grecia 10
HU - Ungheria 10
UY - Uruguay 10
GT - Guatemala 9
PA - Panama 9
ET - Etiopia 8
OM - Oman 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
BA - Bosnia-Erzegovina 7
EU - Europa 7
GH - Ghana 7
QA - Qatar 7
KW - Kuwait 6
LB - Libano 6
PR - Porto Rico 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
MN - Mongolia 5
RS - Serbia 5
SC - Seychelles 5
SY - Repubblica araba siriana 5
Totale 55.439
Salva come PNG Salva come JPEG
Città #
Fairfield 3.903
Ashburn 3.168
Singapore 2.706
Santa Clara 2.390
Hong Kong 1.902
Woodbridge 1.886
Southend 1.737
Houston 1.582
Seattle 1.476
Cambridge 1.306
Wilmington 1.173
Chandler 1.125
Jacksonville 905
San Jose 771
Ann Arbor 759
Dearborn 681
Helsinki 679
Nyköping 675
Beijing 631
London 618
Hefei 590
Ho Chi Minh City 489
Los Angeles 414
Council Bluffs 410
Modena 397
The Dalles 375
Chicago 368
Hanoi 335
New York 312
San Diego 290
Princeton 238
Sofia 234
Milan 224
Seoul 212
Izmir 207
Lauterbourg 194
Eugene 193
Moscow 185
Boardman 172
Buffalo 163
São Paulo 141
Shanghai 138
Dallas 133
Bremen 119
Rome 116
Jakarta 112
Salt Lake City 112
Tokyo 92
Munich 87
Guangzhou 85
Frankfurt am Main 77
Bologna 76
Phoenix 75
Da Nang 72
Tampa 69
Redwood City 68
Redondo Beach 65
Haiphong 64
Amsterdam 62
Atlanta 61
Columbus 60
Orem 60
Vancouver 59
Toronto 58
Montreal 50
Rio de Janeiro 50
Baghdad 44
Dublin 43
Elk Grove Village 43
Johannesburg 43
Naples 41
Chennai 40
Falls Church 40
Mexico City 40
Warsaw 40
Denver 39
Norwalk 39
Tashkent 39
Biên Hòa 38
Brooklyn 37
Miano 37
Stockholm 35
Kilburn 34
Nanjing 34
Melbourne 33
Fremont 32
Belo Horizonte 31
Iasi 31
Philadelphia 31
Ankara 30
Brasília 29
Mumbai 29
San Francisco 29
Kunming 28
Porto Alegre 28
Newark 27
Turin 27
Turku 27
Nairobi 26
Paris 26
Totale 39.406
Salva come PNG Salva come JPEG
Nome #
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial 641
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 496
Anti-Mullerian hormone (AMH): what do we still need to know? 476
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome 457
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 429
MATER protein as substrate of PKCepsilon in human cumulus cells. 418
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach 404
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice 387
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 365
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 361
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 361
From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology 352
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles 346
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos 344
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 342
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 342
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium 337
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study 336
The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH 334
How Much Does AMH Really Vary in Normal Women? 333
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 331
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria 331
FSHR polymorphism p.N680S mediates different responses to FSH in vitro 329
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 327
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol 327
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 324
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 322
Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder 321
Vitamin D and ovarian reserve: making clinical decisions 319
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 319
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 317
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 312
Elevated levels of nitrous dioxide are associated with lower AMH levels: A real-world analysis 312
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 311
Periodontal disease and nitric oxide levels in low risk women with preterm labor 310
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 305
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome 303
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study 302
Primary ovarian insufficiency: autoimmune causes. 299
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 298
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study 298
The physiology and clinical utility of anti-Mullerian hormone in women 295
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro 294
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles 293
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 291
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation 290
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 289
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 286
The management of vaginal agenesis: report of 104 cases 286
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 285
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 285
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 284
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 283
Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea 282
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro 282
Adrenal adenocarcinoma and empty sella syndrome in a 37-year-old woman 279
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 276
The use of ovarian reserve markers in IVF clinical practice: a national consensus 273
Utero-vaginal anastomosis in the treatment of cervical atresia 273
Gonadotrophins modulate cell death-related genes expression in human endometrium 273
The ovarian follicular pool and reproductive outcome in women. 270
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients 269
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 268
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 266
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 264
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes 263
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis 263
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 262
Metformin treatment of PCOS during adolescence and the reproductive period 261
How to personalize ovarian stimulation in clinical practice 260
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 258
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 257
Rectus abdominis muscle endometriosis: Case report and review of the literature 257
Rectovaginal fistula repair using fascia graft of autologous abdominal muscles 253
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age 251
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) 250
Serum anti-Mullerian hormone throughout the human menstrual cycle 249
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study 249
8th World Congress of Gynecological Endocrinology 249
Reply: The two sides of the individualization of controlled ovarian stimulation 247
Anti-Müllerian hormone: clairvoyance or crystal clear? 244
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia 242
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception 241
Soluble L-selectin levels during controlled ovarian hyperstimulation 241
Hormonal and ultrasound markers of ovarian function in a woman with a balanced 1;11 translocation 240
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome 240
Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone 240
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 240
Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium 239
T-shaped uterus: What has been done, what should be done 238
How adenomyosis changes throughout pregnancy: A retrospective cohort study 238
Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply 237
Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy 237
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 237
The journey from the old to the new AMH assay: how to avoid getting lost in the values 236
Recombinant human leptin in women with hypothalamic amenorrhea. 235
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance 235
Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women 235
Pyrexia, leukocytosis and elevated circulating platelets associated to uterine stromal sarcoma with rhabdoid differentiation 235
Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency 235
Totale 29.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 0 0 273
2021/20224.566 176 862 513 160 84 175 345 216 415 356 872 392
2022/20233.625 454 416 349 293 473 434 82 308 414 39 174 189
2023/20243.007 95 153 122 270 479 180 510 456 68 95 131 448
2024/20258.209 260 89 107 581 1.510 1.099 434 449 1.158 519 786 1.217
2025/202618.599 1.057 530 1.581 2.000 2.208 1.427 2.410 1.109 1.884 1.583 1.490 1.320
Totale 55.971